>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Wednesday 08 July 2026
08:30 - 09:30
Session 72: In vitro maturation (IVM)
Wednesday 08 July 2026
08:30 - 09:30: Session 72: In vitro maturation (IVM):
Halil Ruso, United Kingdom
08:30 - 08:50
How to set up an efficient IVM program
09:00 - 09:20
Managing ''difficult'' patients with assistance of IVM
08:30 - 09:30
Session 73: Debate: Microbiome in implantation and early pregnancy: vaginal vs endometrial analysis
08:30 - 09:30: Session 73: Debate: Microbiome in implantation and early pregnancy: vaginal vs endometrial analysis:
Chairperson to be announced
Chairperson to be announced
08:30 - 08:45
Vaginal microbiome analysis is more informative
08:45 - 09:00
Endometrial microbiome analysis is more informative
08:30 - 09:30
Session 74: COCHRANE Exchange session
08:30 - 09:30: Session 74: COCHRANE Exchange session:
Vanessa Jordan, New Zealand
Madelon Van Wely, The Netherlands
08:30 - 08:55
30 years of Cochrane
Cindy M. Farquhar, New Zealand
09:00 - 09:25
Putting evidence in the hands of patients
08:30 - 09:30
Session 75: Policy session: Do we need an international limit on the number of offspring per gamete donor?
08:30 - 09:30: Session 75: Policy session: Do we need an international limit on the number of offspring per gamete donor?:
Carlos Calhaz-Jorge, Portugal
Chairperson to be announced
08:30 - 08:40
Presentation of the ESHRE position paper
Jackson Kirkman-Brown, United Kingdom
08:40 - 09:30
Panel discussion
Maciej Śmiechowski, Poland
Ties van der Meer, The Netherlands
08:30 - 09:30
Session 76: ALMER Exchange session: Reproductive aging
08:30 - 09:30: Session 76: ALMER Exchange session: Reproductive aging:
Ester Polak de Fried, Argentina
Chairperson to be announced
08:30 - 08:50
Reproductive aging in women: current challenges
Pasquale Patrizio, U.S.A.
09:00 - 09:20
Reproductive aging in men: new findings
08:30 - 09:30
Session 77: Renaming PCOS: governance, consensus process, outcomes and global implementation
08:30 - 09:30: Session 77: Renaming PCOS: governance, consensus process, outcomes and global implementation:
Katerina Bambang, United Kingdom
08:30 - 08:50
Name change: why and how
08:50 - 09:05
Global implementation plan
09:05 - 09:15
Patient role and implications
Rachel Morman, United Kingdom
08:30 - 09:30
Session 78: Poster discussion session
08:30 - 09:30: Session 78: Poster discussion session:
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
10:00 - 11:30
Session 79: The next-generation IVF laboratory
10:00 - 11:30: Session 79: The next-generation IVF laboratory:
Sofia Makieva, Switzerland
Chairperson to be announced
10:00 - 10:15
First external validation of an artificial intelligence-based oocyte quality score in an Italian population: association with blastocyst development and clinical outcomes from 20,454 oocytes.
10:15 - 10:30
Near–real-time adaptive machine learning for personalized continuous quality monitoring in IVF laboratories
Inmaculada Vazquez Vazquez, Spain
10:30 - 10:45
Quantified precision and reduced workload using vision-guided robotic micropipette tracking during oocyte and embryo handling: foundational validation for assisted reproductive technology laboratory automation
Huanyu Tian, United Kingdom
10:45 - 11:00
Evaluation of a semi-automated vitrification system based on a novel hydrogel chip for human and mouse oocyte cryopreservation: from survival to live birth
11:00 - 11:15
Evaluation of the efficacy and safety of a novel, microfluidic embryo culture device designed to improve embryo quality and pregnancy outcome during assisted conception treatment
Virginia Pensabene, United Kingdom
11:15 - 11:30
Extended schedule to include weekend for monitoring for IVF treatment does not improve live birth rates
10:00 - 11:30
Session 80: Tailoring ovarian stimulation
10:00 - 11:30: Session 80: Tailoring ovarian stimulation:
Chairperson to be announced
Françoise Shenfield, United Kingdom
10:00 - 10:15
The addition of letrozole to gonadotropins in women undergoing ART: A systematic review and meta-analysis.
Evangelia Katsika, United Kingdom
10:15 - 10:30
Optimising Oocyte Competence in POSEIDON 3&4 Patients: A Prospective Paired-Cycle Evaluation of Recombinant FSH with hMG-Derived LH Activity versus Recombinant FSH plus Recombinant LH
10:30 - 10:45
Delayed oocyte retrieval improves fertilization and pregnancy outcomes in patients with previous fertilization failure: a retrospective study
10:45 - 11:00
The clinical impact of the progesterone-to-estradiol ratio on blastocyst development is confined to low-estradiol IVF cycles
11:00 - 11:15
Targeting insulin resistance prior to in vitro fertilisation cycle in women with polycystic ovary syndrome and metabolic syndrome: a prospective cohort study
11:15 - 11:30
Factors influencing embryonic development in GnRH Agonist-trigger only cycles: a mixed-effects retrospective analysis.
Ana Arnanz, United Arab Emirates
10:00 - 11:30
Session 81: Unravelling pregnancy loss: maternal age, inflammation, uterine environment, and therapeutic innovations
10:00 - 11:30: Session 81: Unravelling pregnancy loss: maternal age, inflammation, uterine environment, and therapeutic innovations:
Chairperson to be announced
Chairperson to be announced
10:00 - 10:15
Thirteen years of chromosomal analysis of products of conception in a single center and subsequent live birth outcomes in recurrent pregnancy loss
10:15 - 10:30
Beyond euploidy: euploid frozen embryo transfer does not improve live birth rates in women with recurrent pregnancy loss
Tatjana Blagojevic, United Arab Emirates
10:30 - 10:45
Changing trends but persistent inequalities: A 20-year joinpoint analysis of miscarriage and ectopic pregnancy admissions in England
sindhu sekar, United Kingdom
10:45 - 11:00
Low-grade inflammation and euploid pregnancy loss
Laura Emilie Vexø, Denmark
11:00 - 11:15
First spatial atlas of human tubal ectopic pregnancy
Miriam Baumgarten, United Kingdom
11:15 - 11:30
Assessment of uterine peristaltic patterns of women with adenomyosis by means of intracavitary electrohysterography: preliminary results
10:00 - 11:30
Session 82: Genetic and molecular basis of infertility
10:00 - 11:30: Session 82: Genetic and molecular basis of infertility:
Chairperson to be announced
Teodora Popa, United Kingdom
10:00 - 10:15
The role and limitations of classical inheritance models and zygosity status in severe female infertility
10:15 - 10:30
Systematic gene–disease assessment and whole exome sequencing in women with unexplained infertility
10:30 - 10:45
Association of mildly deleterious mitochondrial DNA variant profiles with outcomes in medically assisted reproductive technologies: a secondary analysis in two independent cohorts
10:45 - 11:00
Identification of the pathogenic mutations in CUL9 as a novel genetic cause for human early embryonic developmental arrest
11:00 - 11:15
How a specific gene mutation, detected in the seminal fluid, affects testicular spermatogenesis
11:15 - 11:30
Killer-cell ig-like receptor (KIR) polymorphisms influence endometrial dysbiosis, chronic endometritis, and antibiotic response in infertile women
Meda Diana Alecsandru Danceanu, Spain
10:00 - 11:30
Session 83: The Blastocyst story
10:00 - 11:30: Session 83: The Blastocyst story:
Giovanni Coticchio, Italy
Chairperson to be announced
10:00 - 10:15
Impact of IVF versus ICSI on the likelihood of obtaining at least one usable blastocyst in patients who previously failed to form a blastocyst
10:15 - 10:30
Human recombinant hyaluronidase increases denudation time without improving fertilization or blastocyst quality: a paired sibling-oocyte study in donor cycles
Iris Bernal Araque, Spain
10:30 - 10:45
Trophectoderm structural parameters from time-lapse-based 3D blastocyst reconstruction: impacts on clinical and live birth outcomes
10:45 - 11:00
Non-linear association between endometrial thickness and fetal heartbeat, with a potential role for trophectoderm quality under thin endometrium
Hye Jun Lee, Korea, South
11:00 - 11:15
Disentangling embryo scarcity from reproductive competence in POSEIDON Group 3: a mediation-based analysis of cumulative live birth
Varalakshmi Yakasiri, India
11:15 - 11:30
Exploring lineage-specific transcriptomic landscapes of the human blastocyst across developmental, fertilisation method and parental contexts
10:00 - 11:30
Session 84: From metabolism to oocyte health
10:00 - 11:30: Session 84: From metabolism to oocyte health:
Chairperson to be announced
Chairperson to be announced
10:00 - 10:15
Body Mass Index (BMI) does not significantly impact age-adjusted Anti-Müllerian Hormone (AMH) levels: a single site analysis of 7,500 patients
10:15 - 10:30
A preclinical and translational study on the effects of melatonin on ovarian function, gametes and embryonic development in aged mice.
10:30 - 10:45
Molecular biomarkers of mitochondrial function and inflammation in women with poor ovarian response
Anna Sandager Hansen, Denmark
10:45 - 11:00
Beyond association: serum IGF-1 stratifies live birth prognosis and defines growth hormone candidates in advanced-age ART
11:00 - 11:15
Impact of thyroid autoimmunity on reproductive outcomes after intra uterine insemination (IUI) and subsequent IVF/ICSI in euthyroid infertile women: a retrospective cohort study
Laura van Loendersloot, The Netherlands
11:15 - 11:30
IGFBP4 inhibits granulosa cell proliferation via YAP signaling and is elevated in women with premature ovarian insufficiency
10:00 - 11:30
Session 85: Poster discussion session
10:00 - 11:30: Session 85: Poster discussion session:
11:45 - 12:45
Session 86: Advancing safety and quality standards in SoHOs
11:45 - 12:45: Session 86: Advancing safety and quality standards in SoHOs:
Chairperson to be announced
Thomas Strowitzki, Germany
11:45 - 12:05
The new EDQM guide: strengthening safety and quality in MAR
12:15 - 12:35
ECDC Guidelines: preventing donor-derived transmission of communicable diseases in MAR
Jenny Mohseni Skoglund, Sweden
11:45 - 12:45
Session 87: The origin of the human germline
11:45 - 12:45: Session 87: The origin of the human germline:
Jan-Bernd Stukenborg, Sweden
Robin Lovell-Badge, United Kingdom
11:45 - 12:05
The origin of the germline in mammals
João Pedro Alves Lopes, Sweden
12:15 - 12:35
In vitro models to track human post-implantation development
Jitesh Neupane, United Kingdom
11:45 - 12:45
Session 88: Fertility preservation in transgender persons
11:45 - 12:45: Session 88: Fertility preservation in transgender persons:
Kenny Rodriguez-Wallberg, Sweden
Chairperson to be announced
11:45 - 12:05
Options for fertility preservation in persons assigned female at birth
12:15 - 12:35
Options for fertility preservation in persons assigned male at birth
Florian Schneider, Germany
11:45 - 12:45
Session 89: HFEA session: Past, present, and future: Regulating a changing fertility sector
11:45 - 12:45: Session 89: HFEA session: Past, present, and future: Regulating a changing fertility sector:
Julia Chain, United Kingdom
Peter Thompson, United Kingdom
Peter Thompson, United Kingdom
Ying C. Cheong, United Kingdom
Peter Rugg-Gunn, United Kingdom
11:45 - 12:45
Session 90: The perilous bridge between oocyte and embryo life
11:45 - 12:45: Session 90: The perilous bridge between oocyte and embryo life:
Chairperson to be announced
11:45 - 12:05
Safeguarding chromosome alignment in oocytes: role of the kinetochore corona
Adele Marston, United Kingdom
12:15 - 12:35
Actin- and myosin-dependent mechanisms of chromosome segregation in mammalian oocytes
11:45 - 12:45
Session 91: Poster discussion session
11:45 - 12:45: Session 91: Poster discussion session:
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:15
Session 92: What are we putting around our embryos?
14:00 - 15:15: Session 92: What are we putting around our embryos?:
Chairperson to be announced
Marta Jansa Perez, United Kingdom
14:00 - 14:15
Comparative proteomic analysis of commercially available culture media for human preimplantation embryo development
Sebastiaan Mastenbroek, The Netherlands
14:15 - 14:30
The efficacy of hyaluronic acid enriched embryo transfer medium in women undergoing single blastocyst transfer: a multicentre randomised controlled trial
14:30 - 14:45
A comparison of effectiveness for two artificial oocyte activation agents in cycles involving frozen testicular sperm samples
Mehmet Sukru Uzman, Turkey
14:45 - 15:00
Artificial oocyte activation with ionomycin in TESA-ICSI cycles for non-obstructive azoospermia: fertilization, embryo competence and reproductive outcomes
Krishna Chaitanya Mantravadi, India
15:00 - 15:15
Single-oocyte transcriptomics reveals redox- and mitochondria-related constraints during human rescue in vitro maturation and provides evidence for a modulating effect of antioxidant supplementation
14:00 - 15:15
Session 93: Late-breaking research in reproductive endocrinology
14:00 - 15:15: Session 93: Late-breaking research in reproductive endocrinology:
Chairperson to be announced
14:00 - 14:15
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) during preconception and pregnancy: a systematic review and meta-analysis of obstetric and neonatal outcomes
Wendy Vollebregt, The Netherlands
14:15 - 14:30
Prediction of ovulation by digital speech processing in infertile women: a prospective pilot diagnostic accuracy study
14:30 - 14:45
Cumulative live birth rates for single women and women in same-sex relationships undergoing intrauterine insemination with donor sperm – a nationwide population-based cohort study
14:45 - 15:00
Machine learning versus logistic regression for predicting cumulative live birth rates in young low-prognosis patients: A POSEIDON-stratified analysis and web-based tool
15:00 - 15:15
Transvaginal ovarian ablation using a novel system for PCOS-related infertility: effectiveness and exploratory hormonal associations from the ULTRA trials
Saad Amer, United Kingdom
14:00 - 15:15
Session 94: Improving male fertility diagnosis
14:00 - 15:15: Session 94: Improving male fertility diagnosis:
Chairperson to be announced
Meurig Gallagher, United Kingdom
14:00 - 14:15
Genome-wide association study identifies novel loci for semen parameters and testicular volume in idiopathic and unexplained male infertility
14:15 - 14:30
A multiplexed single-sperm functional assay improves diagnostic accuracy and enables targeted compound screening in male infertility
14:30 - 14:45
Molecular signatures of sperm-level selection in humans
Simone Immler, United Kingdom
14:45 - 15:00
Slower male pubertal trajectory is associated with elevated serum FSH level, decreased testicular volume, fat-free mass, altered semen quality, sperm epigenetic markers in young adulthood
Oleg Sergeyev, Russia C.I.S.
15:00 - 15:15
Algorithmic adjustment of sperm motility in mail-in semen analysis causes diagnostic overfitting and systematic risk of clinical misclassification
Ashwin Ramachandran, Australia
14:00 - 15:15
Session 95: Next-generation endometrial research: omics, organoids, and bioengineering
14:00 - 15:15: Session 95: Next-generation endometrial research: omics, organoids, and bioengineering:
Andrea Romano, The Netherlands
Jan Brosens, United Kingdom
14:00 - 14:15
The novel G42C point mutation in the neuropeptide s receptor - role in endometriosis
Giada Polenghi, Australia
14:15 - 14:30
Beyond a localized tumor: integrated urine proteomics and patient-derived 3D organoid models reveal systemic inflammatory and angiogenic factors secreted by uterine fibroids
Fatimah Hussein, United Arab Emirates
14:30 - 14:45
Lipiodol hysterosalpingography modulates endometrial extracellular vesicle signalling and lipid composition during the window of implantation: the NOEL study
Ying C. Cheong, United Kingdom
14:45 - 15:00
Spatial endometrial reconstruction using 3D bioprinting rescues uterine regeneration in intrauterine adhesion
15:00 - 15:15
Spatial transcriptomic insights between eutopic endometrium, ectopic endometriosis and adenomyosis lesions
Katie Jones, United Kingdom
14:00 - 15:15
Session 96: Long-Term Offspring Outcomes and Clinical Safety Strategies
14:00 - 15:15: Session 96: Long-Term Offspring Outcomes and Clinical Safety Strategies:
Samuel Dos Santos-Ribeiro, Portugal
Chairperson to be announced
14:00 - 14:15
Modern IVF clinical practices achieve superior cumulative live birth rates with near-universal single embryo transfer: A multi-cycle cohort study
14:15 - 14:30
Risk of congenital heart defects in children conceived through assisted reproductive technology – a systematic review and meta-analysis
Frederik Kyhl-Svart, Denmark
14:30 - 14:45
Age-dependent disparity in ovarian reserve in PGT-A and non–PGT-A patients: Evidence of selection bias in IVF- PGT-A utilization
SONIA GAYETE LAFUENTE, U.S.A.
14:45 - 15:00
Arterial hypertension and adverse cardiac remodelling in adolescents conceived by assisted reproductive technologies
15:00 - 15:15
Downregulation of Vascular Endothelial Growth Inhibitor (VEGI) mediates hCG-Induced ovarian hyperstimulation: a novel target for therapy
14:00 - 15:15
Session 97: Clinical applications of reproductive genetics
14:00 - 15:15: Session 97: Clinical applications of reproductive genetics:
Chairperson to be announced
Helen O'Neill, United Kingdom
14:00 - 14:15
A reference-free, 3D genome-based method and clinical application for haplotype phasing and carrier status determination of structural rearrangements in preimplantation genetic testing
14:30 - 14:45
A Large-Scale Study on the Occurrence of Ten Severe Microdeletion and Microduplication Syndromes (MMS) across 125,000 Preimplantation Embryos: Detection and Considerations for Clinical Embryo Selection
Christopher Weier, U.S.A.
14:45 - 15:00
Monogenic causes of recurrent euploid pregnancy loss identified by whole-exome sequencing of products of conception: a retrospective cohort study
14:15 - 14:30
Carrier screening panel mismatch: A Bayesian framework to resolve asymmetric panel coverage in reproductive partners
Leslie Burnett, Australia
15:00 - 15:15
Determinants of mosaic embryo developmental capacity: aneuploid clearance kinetics and HIF1A (hypoxia-inducible factor 1-alpha)-modulated depletion
Sheila Yat Sze Kwok, Canada
15:30 - 16:30
Closing reception
15:30 - 16:30: Closing reception: